Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.

Multidrug resistant tuberculosis (MDR-TB), is an emerging public health problem in sub-Saharan Africa (SSA). This study aims to determine the trends in prevalence of MDR-TB among new TB cases in sub-Saharan Africa over two decades.We searched electronic data bases and accessed all prevalence studies...

Full description

Bibliographic Details
Main Authors: Baba Maiyaki Musa, Aishatu L Adamu, Najibah A Galadanci, Bashir Zubayr, Chisom N Odoh, Muktar H Aliyu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5612652?pdf=render
id doaj-5bfff07ad8ff4e9e9b1475e801d02012
record_format Article
spelling doaj-5bfff07ad8ff4e9e9b1475e801d020122020-11-25T01:46:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018510510.1371/journal.pone.0185105Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.Baba Maiyaki MusaAishatu L AdamuNajibah A GaladanciBashir ZubayrChisom N OdohMuktar H AliyuMultidrug resistant tuberculosis (MDR-TB), is an emerging public health problem in sub-Saharan Africa (SSA). This study aims to determine the trends in prevalence of MDR-TB among new TB cases in sub-Saharan Africa over two decades.We searched electronic data bases and accessed all prevalence studies of MDR-TB within SSA between 2007 and 2017. We determined pooled prevalence estimates using random effects models and determined trends using meta-regression.Results: We identified 915 studies satisfying inclusion criteria. Cumulatively, studies reported on MDR-TB culture of 34,652 persons. The pooled prevalence of MDR-TB in new cases was 2.1% (95% CI; 1.7-2.5%). There was a non-significant decline in prevalence by 0.12% per year.We found a low prevalence estimate of MDR-TB, and a slight temporal decline over the study period. There is a need for continuous MDR-TB surveillance among patients with TB.http://europepmc.org/articles/PMC5612652?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Baba Maiyaki Musa
Aishatu L Adamu
Najibah A Galadanci
Bashir Zubayr
Chisom N Odoh
Muktar H Aliyu
spellingShingle Baba Maiyaki Musa
Aishatu L Adamu
Najibah A Galadanci
Bashir Zubayr
Chisom N Odoh
Muktar H Aliyu
Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
PLoS ONE
author_facet Baba Maiyaki Musa
Aishatu L Adamu
Najibah A Galadanci
Bashir Zubayr
Chisom N Odoh
Muktar H Aliyu
author_sort Baba Maiyaki Musa
title Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
title_short Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
title_full Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
title_fullStr Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
title_full_unstemmed Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.
title_sort trends in prevalence of multi drug resistant tuberculosis in sub-saharan africa: a systematic review and meta-analysis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Multidrug resistant tuberculosis (MDR-TB), is an emerging public health problem in sub-Saharan Africa (SSA). This study aims to determine the trends in prevalence of MDR-TB among new TB cases in sub-Saharan Africa over two decades.We searched electronic data bases and accessed all prevalence studies of MDR-TB within SSA between 2007 and 2017. We determined pooled prevalence estimates using random effects models and determined trends using meta-regression.Results: We identified 915 studies satisfying inclusion criteria. Cumulatively, studies reported on MDR-TB culture of 34,652 persons. The pooled prevalence of MDR-TB in new cases was 2.1% (95% CI; 1.7-2.5%). There was a non-significant decline in prevalence by 0.12% per year.We found a low prevalence estimate of MDR-TB, and a slight temporal decline over the study period. There is a need for continuous MDR-TB surveillance among patients with TB.
url http://europepmc.org/articles/PMC5612652?pdf=render
work_keys_str_mv AT babamaiyakimusa trendsinprevalenceofmultidrugresistanttuberculosisinsubsaharanafricaasystematicreviewandmetaanalysis
AT aishatuladamu trendsinprevalenceofmultidrugresistanttuberculosisinsubsaharanafricaasystematicreviewandmetaanalysis
AT najibahagaladanci trendsinprevalenceofmultidrugresistanttuberculosisinsubsaharanafricaasystematicreviewandmetaanalysis
AT bashirzubayr trendsinprevalenceofmultidrugresistanttuberculosisinsubsaharanafricaasystematicreviewandmetaanalysis
AT chisomnodoh trendsinprevalenceofmultidrugresistanttuberculosisinsubsaharanafricaasystematicreviewandmetaanalysis
AT muktarhaliyu trendsinprevalenceofmultidrugresistanttuberculosisinsubsaharanafricaasystematicreviewandmetaanalysis
_version_ 1725018308257775616